Simplified, controlled limb reperfusion and simultaneous revascularization for acute aortic occlusion

Détails

ID Serval
serval:BIB_4C8E0538F612
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Simplified, controlled limb reperfusion and simultaneous revascularization for acute aortic occlusion
Périodique
Journal of Vascular Surgery
Auteur⸱e⸱s
Vogt  P. R., von Segesser  L. K., Pagotto  E., Lijovic  T., Turina  M. I.
ISSN
0741-5214
Statut éditorial
Publié
Date de publication
04/1996
Peer-reviewed
Oui
Volume
23
Numéro
4
Pages
730-3
Notes
Case Reports
Journal Article --- Old month value: Apr
Résumé
A 62-year old patient was admitted with a 24-hour history of ischemia in both legs caused by acute distal aortic occlusion and had had a total loss of sensitivity and motor function for 8 hours. Preoperative serum creatine phosphokinase level was 10,900 IU/ml. During aortofemoral reconstruction, both limbs were reperfused with a potassium-free, blood-cardioplegia-like perfusate. Fasciotomies were not necessary. After operation, maximal serum creatine phosphokinase levels remained below 10,000 IU/ml. Limb sensitivity and motor function were normal. Even for prolonged acute aortoiliac occlusion, a simplified controlled limb-reperfusion may preserve skeletal muscle and nerve function and prevent local and systemic complications caused by reperfusion damage.
Mots-clé
Aortic Diseases/complications/*surgery Arterial Occlusive Diseases/complications/*surgery Blood Cardioplegic Solutions/therapeutic use Creatine Kinase/blood Femoral Artery/surgery Humans Ischemia/etiology/*surgery Leg/*blood supply/innervation/surgery Male Middle Aged Muscle, Skeletal/innervation/physiopathology Paralysis/etiology *Reperfusion/methods Reperfusion Injury/prevention & control Sensation Disorders/etiology
Pubmed
Web of science
Open Access
Oui
Création de la notice
14/02/2008 15:18
Dernière modification de la notice
20/08/2019 15:01
Données d'usage